PTX 111

Drug Profile

PTX 111

Alternative Names: PTX-111

Latest Information Update: 01 Feb 2011

Price : $50

At a glance

  • Originator Phytrix
  • Class Antivirals
  • Mechanism of Action Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Hepatitis B; HIV-1 infections

Most Recent Events

  • 01 Feb 2011 No development reported - Phase-II for Hepatitis B in India (unspecified route)
  • 01 Feb 2011 No development reported - Phase-II for HIV-1 infections in Germany (unspecified route)
  • 19 Dec 2005 Phase-II clinical trials in HIV-1 infections in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top